Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
Merck
Mallinckrodt
Colorcon
Chubb
Cantor Fitzgerald
Chinese Patent Office
McKinsey
US Army

Generated: April 21, 2018

DrugPatentWatch Database Preview

OPHTHETIC Drug Profile

« Back to Dashboard

When do Ophthetic patents expire, and what generic alternatives are available?

Ophthetic is a drug marketed by Allergan and is included in one NDA.

The generic ingredient in OPHTHETIC is proparacaine hydrochloride. There is one drug master file entry for this compound. Eight suppliers are listed for this compound. Additional details are available on the proparacaine hydrochloride profile page.
Drug patent expirations by year for OPHTHETIC
Synonyms for OPHTHETIC
2-(diethylamino)ethyl 3-amino-4-propoxy-benzoate hydrochloride
2-(Diethylamino)ethyl 3-amino-4-propoxybenzoate (HCl)
2-(diethylamino)ethyl 3-amino-4-propoxybenzoate HCl
2-(Diethylamino)ethyl 3-Amino-4-propoxybenzoate Hydrochloride
2-(Diethylamino)ethyl 3-amino-4-propoxybenzoate monohydrochloride
2-(diethylamino)ethyl 3-amino-4-propoxybenzoate;hydrochloride
2-(diethylamino)ethyl 3-azanyl-4-propoxy-benzoate hydrochloride
2-(diethylamino)ethyl3-amino-4-propoxybenzoate hydrochloride
2-diethylaminoethyl 3-amino-4-propoxy-benzoate hydrochloride
2-Diethylaminoethyl 3-amino-4-propoxybenzoate hydrochloride
3-Amino-4-propoxybenzoic Acid 2-(Diethylamino)ethyl Ester Hydrochloride
3-Amino-4-propoxybenzoic acid 2-(diethylamino)ethyl ester hydrochloride
3-amino-4-propoxybenzoicacid2-(diethylamino)ethylesterhydrochloride
499-67-2 (Parent)
5875-06-9
875P069
A832009
AB2000315
AC-3399
AC1LAOF2
ACM499672
AK389891
AKOS015844989
Alcaine
Alcaine (TN)
AN-13015
API0003948
BENZOIC ACID, 3-AMINO-4-PROPOXY-, 2-(DIETHYLAMINO)ETHYL ESTER, HYDROCHLORIDE
Benzoic acid,3-amino-4-propoxy-,2-(diethylamino)ethyl ester
beta-(Diethylamino)ethyl 3-amino-4-n-propoxybenzoate hydrochloride
BFUUJUGQJUTPAF-UHFFFAOYSA-N
Bio-0140
C-55249
C16H27ClN2O3
CAS-5875-06-9
CCG-213513
CHEMBL1200464
Chibro-Heracaine
Chibro-keracaine
CPD000875264
CS-2303
CTK8E3427
D02098
DSSTox_CID_28948
DSSTox_GSID_49022
DSSTox_RID_83213
DTXSID0049022
EINECS 227-541-7
Fluoracaine
HMS1570P20
HY-66012
I01-1787
Jsp000037
K-0087
Keracaine
KS-00000XJ2
KS-5058
MFCD00083467
MFCD00864455
MLS001333067
MLS001333068
MLS002154072
MolPort-003-666-736
NC00586
NCGC00016991-03
NCGC00016991-05
NSC-759896
NSC759896
Ophthain
Ophthetic (TN)
OR030953
P2156
Pharmakon1600-01505688
Proparacaine (Hydrochloride)
Proparacaine Hcl
Proparacaine hydrochloride
Proparacaine hydrochloride (USP)
Proparacaine hydrochloride [USP]
Proparacaine hydrochloride, analytical standard
Proparacaine hydrochloride, United States Pharmacopeia (USP) Reference Standard
Proxymetacaine hydrochloride
Proxymetacaine hydrochloride, Proparacaine
PubChem15202
s1828
SAM002564232
SCHEMBL93880
SMR000875264
TC-010846
Tox21_113547
Tox21_113547_1
U96OL57GOY
UNII-U96OL57GOY

US Patents and Regulatory Information for OPHTHETIC

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Allergan OPHTHETIC proparacaine hydrochloride SOLUTION/DROPS;OPHTHALMIC 012583-001 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
McKinsey
AstraZeneca
Julphar
McKesson
Teva
Dow
Chubb
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.